Share on LinkedInShare on LinkedIn

ARTICLE · 11 DECEMBER 2015

Insight Into Recent PRB Decisions On Pharmaceutical /Biotech Inventions

The Patent Reexamination Board (hereinafter referred to as the PRB) is an organization under the SIPO (State Intellectual Property Office) of China.

ChinaIntellectual Property

The Patent Reexamination Board (hereinafter referred to as the PRB) is an organization under the SIPO (State Intellectual Property Office) of China. Its main functions are to examine appeals against a rejection decision made by the examining departments and to examine requests for invalidation of a granted patent. Although its decisions can be further appealed to Chinese court, the court is only empowered to decide on legality of the decisions. The final decision on the patentability of a patent application or on validity of a patent has to be made by the PRB itself. Especially, the invalidation proceedings very often parallel the civil proceedings on patent infringement as China adopts the so-called "dual track" system for patent validity and patent infringement. Such being the case, the PRB is recognized as a very important organ in the Chinese patent system and its decisions are intensively researched by both local and foreign patent practitioners. This article is a

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from